Knownwell, the Andreessen Horowitz-backed provider of hybrid primary care and metabolic care including weight, announced it has acquired AI-enabled precision metabolic health management company Alfie Health to enhance its clinical decision support offerings.
Boston-based Knownwell describes itself as a provider of primary care and metabolic health services, including weight management, delivered in person and virtually. The company has brick-and-mortar locations in Texas and New England, and plans to open an office in Minnesota later this year.
Alfie offers an AI-enabled platform called ObesityRx, which analyses medical history to determine which treatments will most effectively improve an individual's metabolic health.
“As part of the acquisition, standalone access to the Alfie platform and Alfie-affiliated clinics has been terminated,” the New York-based company said on its website.
The acquisition will integrate Alfie's ObesityRx platform into Knownwell's care model, which Knownwell says will strengthen its value-based care infrastructure and enhance clinical decision support.
KnownWell also announced the appointments of James Chaukos as its first chief operating officer and John Phleger as chief growth officer.
Chaukos was previously co-founder, chief operating officer and chief financial officer of Cricket Health (now InterWell Health), while Pfleger previously worked at Carbon Health.
“This acquisition by KnownWell helps us fulfill our mission of providing best-in-class obesity management to patients in need,” Alexander Singh, founder and CEO of Alfie Health, said in a statement. “KnownWell's leadership, clinical expertise and hybrid model make them a leader in obesity management, and their hybrid model will enhance our high-touch approach to care and improve patient outcomes.”
Larger trends
knownwell was founded in January last year with $4.5 million in seed funding led by Flare Capital Partners and secured $20 million in Series A funding in December.
Last year, Alfie raised $2.1 million for his weight loss platform.
Another company focused on weight management is Lumen, a maker of portable metabolic monitoring devices, which secured $62 million in Series B funding in 2022.
